Chad Gwaltney

ORCID: 0000-0001-8130-2024

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study”.

Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study

Neurology Clinical Practice(2023)10.1212/cpj.0000000000200181

N/A

0.342DataRank · unranked

8 citations

Priya S. Kishnani, Cristina Ivanescu, Giulio Flore, Chad Gwaltney, Nadine A. M. E. van der Beek +8 more

Support for incentive-sensitization theory in adolescent ad libitum smokers using ecological momentary assessment.

Experimental and Clinical Psychopharmacology(2023)10.1037/pha0000669

N/A

0DataRank · unranked

1 citations

Robert D. Dvorak, Ardhys N. De Leon, Emily K. Burr, Angelina V. Leary, Emma Hayden +4 more

Signs, symptoms, and health-related quality of life in MELAS: measuring what’s important from the patient and clinician perspectives

Journal of Patient-Reported Outcomes(2025)10.1186/s41687-025-00962-6

N/A

0DataRank · unranked

1 citations

Benjamin Banderas, Marisa Brimmer, Lily Settel, Sari Berger, Alan L. Shields +14 more